Ane L Appelt
Ane L Appelt
University of Leeds and St James’s University Hospital
Verified email at - Homepage
TitleCited byYear
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
AL Appelt, J Pløen, H Harling, FS Jensen, LH Jensen, JCR Jørgensen, ...
The Lancet Oncology 16 (8), 919-927, 2015
Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients
HD Nissen, AL Appelt
Radiotherapy and Oncology 106 (1), 28-32, 2013
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre …
MJM van der Valk, DE Hilling, E Bastiaannet, EMK Kranenbarg, GL Beets, ...
The Lancet 391 (10139), 2537-2545, 2018
Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy
AL Appelt, J Pløen, IR Vogelius, SM Bentzen, A Jakobsen
International Journal of Radiation Oncology* Biology* Physics 85 (1), 74-80, 2013
Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses
A Jakobsen, J Ploen, T Vuong, A Appelt, J Lindebjerg, SR Rafaelsen
International Journal of Radiation Oncology* Biology* Physics 84 (4), 949-954, 2012
Cell‐free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer
KLG Spindler, AL Appelt, N Pallisgaard, RF Andersen, I Brandslund, ...
International Journal of Cancer 135 (12), 2984-2991, 2014
Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart
AL Appelt, IR Vogelius, SM Bentzen
Clinical Oncology 25 (3), 147-152, 2013
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth …
KLG Spindler, N Pallisgaard, AL Appelt, RF Andersen, JV Schou, ...
European Journal of Cancer 51 (17), 2678-2685, 2015
Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors
AL Appelt, IR Vogelius, KP Farr, AA Khalil, SM Bentzen
Acta Oncologica 53 (5), 605-612, 2014
KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
KG Spindler, AL Appelt, N Pallisgaard, RF Andersen, A Jakobsen
British journal of cancer 109 (12), 3067-3072, 2013
Long-Term Results of a Randomized Trial in Locally Advanced Rectal Cancer: No Benefit From Adding a Brachytherapy Boost
AL Appelt, IR Vogelius, J Pløen, SR Rafaelsen, J Lindebjerg, ...
International Journal of Radiation Oncology* Biology* Physics 90 (1), 110-118, 2014
Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study …
AJM Rombouts, I Al-Najami, NL Abbott, A Appelt, G Baatrup, S Bach, ...
BMJ Open 7 (12), e019474, 2017
Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an …
SA Chadi, L Malcomson, J Ensor, RD Riley, CA Vaccaro, GL Rossi, ...
The Lancet Gastroenterology & Hepatology 3 (12), 825-836, 2018
Late Relapses in Stage I Testicular Cancer Patients on Surveillance
MS Mortensen, J Lauritsen, MGG Kier, M Bandak, AL Appelt, M Agerbæk, ...
European urology 70 (2), 365-371, 2016
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study
DS Møller, TB Nielsen, C Brink, L Hoffmann, CM Lutz, MD Lund, ...
Radiotherapy and Oncology 124 (2), 311-317, 2017
Intratumoral heterogeneity of MicroRNA expression in rectal cancer
AHM Eriksen, RF Andersen, BS Nielsen, FB Sørensen, AL Appelt, ...
PloS one 11 (6), 2016
A method to adjust radiation dose–response relationships for clinical risk factors
AL Appelt, IR Vogelius
Radiotherapy and Oncology 102 (3), 352-354, 2012
Dose-response of acute urinary toxicity of long-course preoperative chemoradiotherapy for rectal cancer
AL Appelt, SM Bentzen, A Jakobsen, IR Vogelius
Acta Oncologica 54 (2), 179-186, 2015
Technological advances in radiotherapy of rectal cancer: opportunities and challenges
AL Appelt, D Sebag-Montefiore
Current opinion in oncology 28 (4), 353-358, 2016
Metal artefact reduction for accurate tumour delineation in radiotherapy
DG Kovacs, LA Rechner, AL Appelt, AK Berthelsen, JC Costa, J Friborg, ...
Radiotherapy and Oncology 126 (3), 479-486, 2018
The system can't perform the operation now. Try again later.
Articles 1–20